about
Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote ca...
Read More
5.45
0.00
(0.00%)
1.2M
XNAS Volume
XNAS 08 Apr, 2026 5:30 PM (EDT)
Low Financial Strength
Expensive Valuation
Technically Bearish
Weak Stock
These stocks have poor scores across the board. Investors should be very cautious with these stocks
View Similar
Embed DVM
Verastem Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..